Race for Life events cancelled due to COVID-19

Cancer Research UK today announced that it has made the difficult decision to cancel Race for Life events across the UK this year as a result of COVID-19. Cancer Research UK today announced that it has made the difficult decision to cancel Race for Life events across the UK this year as a result of COVID-19.

4 June 2020

• Health & Medicine

Over 2 million people in backlog for cancer care

Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK. Around 2.4 million people in the UK are waiting for cancer screening, further tests or cancer treatment according to a new analysis by Cancer Research UK.

1 June 2020

• Health & Medicine

Repurposed drug tested in COVID-19 trial, thanks to Cancer Research UK know-how

Cancer Research UK and its partners launch clinical trial to test if a drug that’s used to treat inflammation of the pancreas can help people with COVID-19 Cancer Research UK and its partners launch clinical trial to test if a drug that’s used to treat inflammation of the pancreas can help people with COVID-19

29 May 2020

• Science & Technology

AI could predict risk of lung cancer coming back

Computer scientists working with pathologists have trained an AI tool to determine which lung cancer patients have a higher risk of their disease coming back Computer scientists working with pathologists have trained an AI tool to determine which lung cancer patients have a higher risk of their disease coming back

27 May 2020

• Health & Medicine

Immunotherapy for triple negative breast cancer approved for NHS in England 

Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer. Atezolizumab used in combination with nab-paclitaxel is the first immunotherapy available for triple negative breast cancer.

26 May 2020

• Health & Medicine

Breast and ovarian cancer drug effective in advanced prostate cancer

A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer. A targeted cancer drug, already licensed for treating some breast and ovarian cancers, is found to be effective for some men with advanced prostate cancer.

1 May 2020

• For Supporters

Join the Race for Life at Home straight from your living room

With Race for Life events postponed, Cancer Research UK is encouraging the nation to keep active and united by signing up for Race for Life at Home. With Race for Life events postponed, Cancer Research UK is encouraging the nation to keep active and united by signing up for Race for Life at Home.

20 April 2020

• Health & Medicine

Cancer care needs mass COVID-19 testing

With pressures mounting on the health service, Cancer Research UK calls for widespread testing to prevent unnecessary cancer deaths With pressures mounting on the health service, Cancer Research UK calls for widespread testing to prevent unnecessary cancer deaths

17 April 2020

• Policy & Insight
• Charity News

Cancer Research UK response to government's charity package

Cancer Research UK chief executive Michelle Mitchell responds to the government announcement of a £750 million support package for charities. Cancer Research UK chief executive Michelle Mitchell responds to the government announcement of a £750 million support package for charities.

8 April 2020

• Charity News

Cancer Research UK announces cuts to current funding

Cancer Research UK has announced that it has taken the difficult decision to cut funding to its existing grants and institutes by £44 million. Cancer Research UK has announced that it has taken the difficult decision to cut funding to its existing grants and institutes by £44 million.

7 April 2020

• Charity News

Cancer Research UK estimates 25 per cent drop in fundraising income due to coronavirus

Cancer Research UK expects to see its fundraising income decline by up to 25 per cent as a direct result of the COVID-19 coronavirus Cancer Research UK expects to see its fundraising income decline by up to 25 per cent as a direct result of the COVID-19 coronavirus

30 March 2020

• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020